Volume 61, Number 1, February2016
Editorial | |
1 | |
|
|
Original Articles | |
3 |
Ido Sirota, M.D., M.H.A., Daniel E. Stein, M.D., Mario Vega, M.D., and Martin D. Keltz, M.D.
Obese women with polycystic ovary syndrome are at significant risk of having elevated insulin resistance and β-cell activity as compared to overweight and healthy-weight women with polycystic ovary syndrome.
|
|
|
11 |
Juan S. Sandoval, M.D., Ryan G. Steward, M.D., Chen Chen, M.S., Yi-Ju Li, Ph.D., Thomas M. Price, M.D., and Suheil J. Muasher, M.D.
High peak E2/mature oocyte ratio was found to be associated with lower clinical pregnancy, ongoing pregnancy, and live birth rates in fresh, autologous, GnRH antagonist intracytoplasmicsperm injection cycles.
|
|
|
17 |
Lee A. Richter, M.D., Jenine Boileau, M.S., Megan Janni, M.S., Eshetu Tefera, M.S., and Cheryl B. Iglesia, M.D.
The authors determine the rate of ureteral injury during transvaginal uterosacral ligament suspension procedures and review the impact of surgeon level of training on this occurrence.
|
|
|
22 |
William F. Rayburn, M.D., M.B.A., Christine Q. Liu, Ph.D., Erika C. Elwell, B.A., and Rebecca G. Rogers, M.D.
Expansion of physician faculty in obstetrics and gynecology over the past 40 years has led to greater diversity that is now reflective of medical student demographics.
|
|
|
27 |
Sekifa B. Polat, M.D., Oguzhan Oguz, M.D., Muhammed Sacikara, M.D., Fatma Neslihan Cuhaci, M.D., Berna Evranos, M.D., Reyhan Ersoy, M.D., and Bekir Cakir, M.D.
Polycystic ovary syndrome is not correlated with thyroid autoimmunity, but serum luteinizing hormone level is correlated with thyroid volume in polycystic ovary syndrome patients.
|
|
|
33 |
Adam Ostrzenski, M.D., Ph.D., Dr.Hab.
The author recommends that ACOG and other gynecologic societies around the world consider revising their recommendations for practicing cosmetic-plastic gynecology in order to correct significant deficiencies in scientific integrity.
|
|
|
39 |
Fan Wang, M.D., Mi Xiao, M.D., Xiao-Jie Lin, M.D., Siddiq Muhammad, M.D., Xian-Hua Piao, M.D., Ph.D., and Li Liu, M.D., Ph.D.
Heme oxygenase�1 and leukemia inhibitory factor participate with Treg cells in the maternal-fetal interface, producing a unique immune microenvironment in a lipopolysaccharide-induced, late pregnancy, preterm birth mouse model.
|
|
|
47 |
Anne R. Fernandez, Ph.D., Siti Z. Omar, M.Med., and Ruby Husain, Ph.D.
This case-control study investigates the relationship between genistein intake and the incidence of preeclampsia.
|
|
|
52 |
Selen Dogan, M.D., �zg�r �zy�nc�, M.D., and Zeliha Atak, M.D.
Fibroids during pregnancy increase hospitalization for pain but do not increase perinatal complications. Performing myomectomy increases the need for transfusion but does not increase the need for hysterectomy and other life-threatening complications.
|
|
|
58 |
Yaakov Melcer, M.D., Ron Maymon, M.D., Zvi Vaknin, M.D., Moty Pansky, M.D., Sonia Mendlovic, M.D., Oshri Barel, M.D., and Noam Smorgick, M.D.
Ovarian ectopic pregnancies are commonly diagnosed at time of rupture and are associated with hemoperitoneum and need for blood transfusion.
|
|
|
63 |
Kelly S. Milman, Sc.B., Justin T. Diedrich, M.D., Qiuhong Zhao, M.S., and Jeffrey F. Peipert, M.D., Ph.D.
Five years later, CHOICE participants are more likely to have health insurance than they were at the time of enrollment in the CHOICE Project.
|
|
|
Case Reports | |
69 |
Kyle J. Tobler, M.D., Sarah Oman, M.D., and Lisa A. Kolp, M.D.
Retained products of conception may increase the risk for intravasation of both hysterosalpingogram contrast and hysteroscopic distention media.
|
|
|
73 |
Joao Correia De Pinho, B.Pharm., M.D., Lusine Aghajanova, M.D., Ph.D., and Christopher N. Herndon, M.D.
Prepubertal gynecomastia can occur secondary to transdermal exposure to compounded nonformulary hormonal replacement therapy, a diagnostic challenge with unforeseen consequences.
|
|
|
78 |
Panagiotis Drakopoulos, M.D., Nicola Pluchino, M.D., Ph.D., Paul Bischof, M.D., Pablo Cantero, M.D., Patrick Meyer, M.D., and Didier Chardonnens, M.D.
Growth hormone replacement therapy in conjunction with the conventional controlled ovarian hyperstimulation and IVF/ET enabled good endometrial development and better ovarian response to gonadotropins, leading to a successful delivery of a twin pregnancy.
|
|
|
83 |
Adam Close, B.Sc., Alexis Gimovsky, M.D., and Charles Macri, M.D., F.A.C.O.G., F.A.C.S.
A 36-year-old woman at 33+ weeks� gestation who presented with cough and fever was later diagnosed with Legionnaires disease and recovered after a course of antibiotics and cesarean delivery.
|
|
|
87 |
Lauren Tracy, M.D., Molly Baker, M.D., and Alessio Pigazzi, M.D., Ph.D.
The presentation, diagnosis, and treatment of an uncommon case of colouterine fistula is discussed, with world literature of prior cases of colouterine fistulae reviewed.
|